Why is Gennex Lab. falling/rising?

As of 23-Jul, Gennex Laboratories Ltd is experiencing a decline in its stock price, currently at 13.30, reflecting a decrease of 0.03 or 0.23%. The stock has underperformed its sector by 0.74% today and has been on a consecutive fall for the last four days, resulting in a total drop of 4.32% during this period. Despite a positive long-term growth outlook, with operating profit increasing at an annual rate of 56.07%, the stock has generated a negative return of 4.11% over the past year. The company's low ROE of 8.70% indicates poor management efficiency, which may contribute to investor concerns. Additionally, a significant drop in delivery volume by 32.54% against the 5-day average suggests falling investor participation, further impacting the stock's performance. In the broader market context, Gennex Laboratories Ltd's short-term performance over the past week shows a decline of 1.70%, while the benchmark Sensex has increased by 0.11%. This underperformance relative to the benchmark may reflect investor sentiment and market conditions that are unfavorable for the stock. Although the company has seen rising promoter confidence with a 1.41% increase in stake, the overall negative sentiment stemming from recent financial results, including a significant drop in profit before tax and profit after tax, may overshadow these positive factors. The stock's trading at a discount compared to its peers could indicate potential value, but the current trends suggest that investors are cautious, leading to the recent price decline.